Yuyu Pharma, Inc.
Financials
Valuation Metrics
Yuyu Pharma, Inc.'s Market Cap is ₩713B. At end of 2025 it was ₩865B. Ranked #1525 of 2,421 in KR market (top 63%), #630 of 781 on KOSPI (top 81%), #167 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 72%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 71.31B KRW | KR#1,525/2,421 Sec#167/231 |
| Revenue | 144.37B KRW | KR#1,206/2,421 Sec#72/231 |
| Net Income | 12.43B KRW | KR#893/2,421 Sec#58/231 |
| Total Assets | 207.88B KRW | KR#1,285/2,421 Sec#93/231 |
| Net Assets | 146.18B KRW | KR#1,155/2,421 Sec#83/231 |
| Employees | 257 | KR#910/2,421 Sec#76/231 |
| Value | ||
| P/E | 5.74x | KR#421/2,421 Sec#15/231 |
| P/B | 0.49x | KR#776/2,421 Sec#35/231 |
| P/S | 0.49x | KR#917/2,421 Sec#42/231 |
| EV/EBITDA | 6.27x | KR#321/2,421 Sec#9/231 |
| FCF Yield | 10.69% | KR#582/2,421 Sec#20/231 |
| Profitability | ||
| ROE | 8.50% | KR#738/2,421 Sec#52/231 |
| ROA | 5.98% | KR#628/2,421 Sec#50/231 |
| Op. Margin | 9.12% | KR#581/2,421 Sec#49/231 |
| Revenue Growth | 6.69% | KR#1,091/2,421 Sec#105/231 |
| Financial Health | ||
| Debt Ratio | 42.21% | KR#839/2,421 Sec#97/231 |
| Total Debt | 32.18B KRW | KR#1,191/2,421 Sec#88/231 |
| FCF | 7.62B KRW | KR#791/2,421 Sec#47/231 |
| Cash | 20.99B KRW | KR#1,226/2,421 Sec#89/231 |
| Current Ratio | 1.89x | KR#921/2,421 Sec#103/231 |
| Net Debt/EBITDA | 0.85x | KR#718/2,421 Sec#48/231 |
| Dividend | ||
| Div. Yield | 3.00% | KR#631/2,421 Sec#31/231 |
| Div. Growth | 15.00% | KR#510/2,421 Sec#28/231 |
| Performance | ||
| 1Y Return | -12.44% | KR#1,030/2,421 Sec#67/231 |
| 1M Return | 3.23% | KR#903/2,421 Sec#64/231 |
| From 52W High | -24.80% | KR#379/2,421 Sec#21/231 |
| 1Y MDD | -27.53% | KR#189/2,421 Sec#12/231 |
| Trading | ||
| Volume | 31,887 shares | KR#1,351/2,421 Sec#130/231 |
| Trading Value | 122.3M KRW | KR#1,471/2,421 Sec#149/231 |
| Foreign Own. | 2.60% | KR#1,425/2,421 Sec#133/231 |
| Per Share | ||
| EPS | 669 KRW | KR#881/2,421 Sec#62/231 |
| BPS | 7,862 KRW | KR#1,136/2,421 Sec#82/231 |
Company Info
Established in 1941 as Yuhan Trading and listed on the securities market in 1975, the company is a pharmaceutical firm manufacturing and selling pharmaceuticals and health functional foods from its plant in Jecheon, Chungcheongbuk-do. It supplies specialized pharmaceuticals to domestic hospitals and clinics, operates a contract manufacturing business, and exports finished pharmaceuticals to various countries. With subsidiaries including YUYU Healthcare, YUYU Medicals, and YUYU VENTURES, the company is diversifying its business, including expansion into animal pharmaceuticals. The company is headquartered in Jecheon, Chungcheongbuk-do.